Onco Actu du 16 juillet 2015

	4. Dépistage, diagnostic et pronostic
Running A Few Tests On Theranos: Can Elizabeth Holmes Revolutionize Diagnostics? [Forbes] Does any of this mean for sure that Theranos is going to revolutionize the way we get blood tests? No. Revolutions are hard. And it would be nice to have more information on what is going on inside Theranos’ black box. But what we can see is promising.
	4.10 Dép., diag. & prono. - Poumon
Test May Identify Poor Prognosis for Some Patients with Lung Cancer [National Cancer Institute] In the retrospective study, patients with stage I lung cancer (adenocarcinoma) whose tumors expressed all three markers were far more likely to die from their cancer or to have a recurrence than patients whose tumors did not express these markers.
	4.12 Biopsies liquides
Possible Diagnostic Marker for Pancreatic Cancer Found [National Cancer Institute] “This work demonstrates for the first time that circulating vesicles in blood can be a source of specific and reliable diagnostic biomarkers for cancer.”
	5. Traitements
Cancer killer combination could make cells more sensitive to chemo [Cancer Research UK] Chemotherapy is still an important weapon in our fight against cancer – and one that’s likely to still be around for some time to come – but vital research like this is making it kinder and more effective.
	5.2 Pharma
Takeda hands in its Velcade successor with blockbuster ambitions [Fierce Biotech] Ixazomib, another product of Takeda's $8.8 billion acquisition of Millennium Pharmaceuticals back in 2008, is the company's best bet in oncology after late-stage setbacks for the ​lymphoma treatment alisertib and prostate cancer drug orteronel.
	5.3 Traitements - FDA, EMA,...
FDA, European Commission and EMA reinforce collaboration to advance medicine development and evaluation [EMA] The focus of the cluster reviews during this bilateral was pharmacovigilance, biosimilars, paediatrics and veterinary medicines.
	6. Lutte contre les cancers
Working together to beat cancer in young people [Cancer Research UK] It won’t be easy guaranteeing that every young person diagnosed with cancer lives the longest, happiest life possible. But with many of the world’s leading children’s cancer researchers working together, this can happen that much sooner.
Precision Medicine Catapult HQ set for Cambridge [PHG Foundation] The Precision Medicine Catapult, headquartered on the Cambridge Biomedical Campus will aim to make the UK the most attractive place in the world to develop precision medicine.
Next Round of Grant Solicitations for Provocative Questions Announced [National Cancer Institute] The PQ Initiative is highly competitive, Dr. Greenspan said; less than 15 percent of applications in previous application cycles were funded.
	6.7 DMP, Big Data & applis
How CancerLinQ™ Can Benefit People Living With Cancer [The ASCO Post] CancerLinQ promises to unlock the wealth of data stored in individual patient electronic health records and provide us with answers.